Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium

Journal of Nuclear Medicine

Volumn 37, Issue 10, 1996, Pages 1631-1636

  Bax, Jeroen J ^a   Visser, Frans C ^b   Blanksma, Paul K ^b   Veening, Magreet A ^b   Tan, Eng S ^b   Willemsen, Antoon T M ^b   Van Lingen, Arthur ^b   Teule, Gerrit J J ^b   Vaalburg, Willem ^b   Lie, Kong I ^b   Visser, Cees A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

fluorine 18 fluorodeoxyglucose; myocardial viability; PET; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; MALE; MYOCARDIAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AMMONIA; CORONARY DISEASE; DEOXYGLUCOSE; ECHOCARDIOGRAPHY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE CLAMP TECHNIQUE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NITROGEN RADIOISOTOPES; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10144246573     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32:565-578.
2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
3. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
4. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-1353.
5. 18F-fluorodeoxyglucose using single-photon emission computed tomography. Eur Heart J 1993;14:1675-1682.
6. Bax JJ, Visser FC, van Lingen A, et al. Relation between myocardial uptake of thallium-201 chloride and fluorine-18-fluorodeoxyglucose imaged with SPECT in normal volunteers. Eur J Nucl Med 1995;22:56-60.
7. 18F-fluorodeoxyglucose imaging by single-photon emission computed tomography. Clin Nucl Med 1995;20:466-490.
8. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-995.
9. Stoll HP, Hellwig N, Alexander C, Oezbek C, Schieffer H, Oberhausen E. Myocardial metabolic imaging by means of fluorine-18-fluorodeoxyglucose/technetium-99m-sestamibi dual-isotope single-photon emission tomography. Eur J Nucl Med 1994;21: 1085-1093.
10. 18F]FDG-PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995;36:176-179.
11. Bax JJ, Cornel JH, Visser FC, et al. The role of fluorine-18-fluorodeoxyglucose single-photon emission computed tomography in predicting reversibility of regional wall motion abnormalities after revascularization. In: van der Wall EE, Blanksma PK, Niemeyer MG, Paans AMJ, eds. Cardiac positron emission tomography. Dordrecht: Kluwer Academic Publishers; 1995:75-85.
12. Jaarsma W, Visser CA, Eenige van MJ, et al. Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardium. Am J Cardiol 1986;58:394-398.
13. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986;27:641-652.
14. Knuuti J, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-1262.
15. 18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med 1978;19:1311-1319.
16. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
17. Van Lingen A, Huijgens PC, Visser FC, et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992;19:315-321.
18. Bax JJ, Cornel JH, Visser FC, et al. Functional recovery after revascularization predicted by quantitative FDG-SPECT [Abstract]. Eur J Nucl Med 1995;22:798.
19. Blanksma PK, Willemsen ATM, Meeder JG, et al. Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med 1995;36:153-158.
20. De Jong RM, Blanksma PK, Willemsen ATM, et al. Posterolateral defect of the normal human heart investigated with nitrogen-13-ammonia and dynamic PET. J Nucl Med 1995;36:581-585.
21. Bellina CR, Parodi O, Camici P, et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of myocardial blood flow. J Nucl Med 1990;31:1335-1343.
22. Schelbert HR, Phelps ME, Huang SC, et al. Nitrogen-13-ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-1272.
23. Krivokapich J, Huang SC, Phelps ME, et al. Estimation of myocardial metabolic rate for glucose using fluoro-18-deoxyglucose. Am J Physiol 1982;12:H884-H895.
24. Ratib O, Phelps ME, Huang SC, et al. Positron emission tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577-586.
25. AHA Committee Report. A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975;51(suppl 4):5-40.
26. Bax JJ, Visser FC, van Lingen A, et al. Image quality of cardiac FDG studies in diabetics using hyperinsulinemic glucose clamping [Abstract]. J Nucl Med 1995;36: 36P/37P.
27. Vom Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 1993;88:395-404.
28. Altehoefer C, Vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569-574.
29. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comp Assist Tomography 1979;3:299-308.
30. 18F-Fluorodeoxyglucose. Circulation 1991;83:26-37.
31. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006-1015.
32. Soufer R, Dey HM, Lawson AJ, Wackers FJT, Zaret BL. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study. J Nucl Med 1995;36:180-187.
33. Sandler MP, Videlefsky S, Delbeke D, et al. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18-fluorodeoxyglucose/ technetium-99m-MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995;26:864-869.